GB2422311A - Treatment of blood to cure disease - Google Patents
Treatment of blood to cure disease Download PDFInfo
- Publication number
- GB2422311A GB2422311A GB0501156A GB0501156A GB2422311A GB 2422311 A GB2422311 A GB 2422311A GB 0501156 A GB0501156 A GB 0501156A GB 0501156 A GB0501156 A GB 0501156A GB 2422311 A GB2422311 A GB 2422311A
- Authority
- GB
- United Kingdom
- Prior art keywords
- disease
- cure
- immune system
- patient
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000008280 blood Substances 0.000 title claims abstract description 10
- 210000004369 blood Anatomy 0.000 title claims abstract description 10
- 201000010099 disease Diseases 0.000 title claims description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims description 23
- 239000002253 acid Substances 0.000 claims abstract description 7
- 238000000034 method Methods 0.000 claims abstract 2
- 239000003513 alkali Substances 0.000 claims description 6
- 238000012360 testing method Methods 0.000 claims description 3
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 241001465754 Metazoa Species 0.000 claims description 2
- 235000013330 chicken meat Nutrition 0.000 claims description 2
- 210000000987 immune system Anatomy 0.000 claims 7
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 241000928610 Coula Species 0.000 claims 1
- 206010062717 Increased upper airway secretion Diseases 0.000 claims 1
- 241001122767 Theaceae Species 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 208000026435 phlegm Diseases 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 230000028993 immune response Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3687—Chemical treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cardiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Anesthesiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A method of treating a sample of blood from a diseased patient wherein said blood is subjected to acid or alkaline treatment. The blood is then returned to the patient to stimulate an immune response.
Description
A General Cure To Diseases which does rMt use a horse or an egg.
Diseased matter cells which could be dotain from the blood of the patient and 5bjecting this to alkali/acid and then in solution applying this to the iuufle system of a human so that this fights the reduced strength disease and ant ibodles to the disease are thus produced from which a cure to the disease can be obtained to be used on the patient too, so that not even a chickens egg let alone a horse need be used risked cure can be tested on a petri dish using standard testing methods 50 that a human need not be risked too.
Applying this cure principle of engineerinc the mould and antibodieS this solution can be applied to animals too-
Claims (1)
- General Cure To Diseases Idea 3 Claims 1. Diseased matter cells whichcoula be obtained from the blood of the patient and subjecting this to alkali/acid and then in solution app!ying this to the immune system of a human so that this fights the reduced strength disease and antibodies to the disease are thus produced from which a cure to the disease can be obtained to b'e used on the patient too, so that not even a chickens egg let alone a horse need be used risked cure can be tested on a petri dish using standard testing methods so that a human need not be risked too, applying this cure principle of engineering the mould and antibodies this solution can be applied to animals too, the General Cure To Diseases Idea 3 is substantially as described herein with reference to the accompanyingdescription.Amendments to the claims have been filed as follows General Cure To Diseases Idea 3 Claim 1. A General Cure To Diseases Idea which does not risk an egg or horse, a sample of blood of the patient is taken as it contains the disease, such as Aids, and can keep the disease alive initially, the disease in the blood is then subjected to acid/alkali bombardment by acid/alkali solution being put into the blood sample so that the disease cells outer shell is weakened, the acid/alkali bombardment is due to the disease being weakened as far as possible without i-t being destroyed this can be determined using calculus, the weakened disease cell is then put into a fresh sample of blood containing the immune system, the immune system of which attacks the weakened disease cells such that the resultant reprogrammed and strengthened immune system can combat even disease cells which have not been weakened by acid/alkali bombardment, a mould created such as by a solution of phlegm and resultant immune system on pieces of paper water milk sugar coffee tea subjected to oxygen and sunlight in a vat can thus be produced based on the resultant immune system and vat production commenced to produce further anti disease immune system by allowing the mould to grow and multiply, the mould thus produced can then in solution be tested using standard testing techniques such as seeing whether it will ward off disease cells that are pu.t in the vicinity of the mould, and then if it does it could be injected into the patient to cure the patient, the mould can be used to inoculate or vaccinate a patient, the General Cure To Diseases Idea 3 is substantially as described herein with reference tothe accompanying description.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0501156A GB2422311A (en) | 2005-01-20 | 2005-01-20 | Treatment of blood to cure disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0501156A GB2422311A (en) | 2005-01-20 | 2005-01-20 | Treatment of blood to cure disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB0501156D0 GB0501156D0 (en) | 2005-03-02 |
| GB2422311A true GB2422311A (en) | 2006-07-26 |
| GB2422311A8 GB2422311A8 (en) | 2006-08-18 |
Family
ID=34259377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB0501156A Withdrawn GB2422311A (en) | 2005-01-20 | 2005-01-20 | Treatment of blood to cure disease |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB2422311A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB901431A (en) * | 1958-01-20 | 1962-07-18 | Celanese Corp | Improvements in the production of cellulose triacetate filamentary materials |
| WO1982002841A1 (en) * | 1981-02-18 | 1982-09-02 | University Patents Inc | Precipitation of proteins |
| EP0091784A2 (en) * | 1982-04-07 | 1983-10-19 | Baylor College of Medicine | Products for use in treating cancer |
| EP0168801A2 (en) * | 1984-07-20 | 1986-01-22 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Apparatus for separating proteins from blood plasma |
| US4663049A (en) * | 1984-07-05 | 1987-05-05 | University Of Utah | Process for therapeutic dissociation of immune complexes and removal of antigens |
| WO1988001507A1 (en) * | 1986-08-01 | 1988-03-10 | Rubinstein Alan I | A method to treat blood |
| WO2001080866A1 (en) * | 2000-04-26 | 2001-11-01 | Gauchet Jean Yves | Immunostimulatory pharmaceutical composition and its use protocol |
-
2005
- 2005-01-20 GB GB0501156A patent/GB2422311A/en not_active Withdrawn
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB901431A (en) * | 1958-01-20 | 1962-07-18 | Celanese Corp | Improvements in the production of cellulose triacetate filamentary materials |
| WO1982002841A1 (en) * | 1981-02-18 | 1982-09-02 | University Patents Inc | Precipitation of proteins |
| EP0091784A2 (en) * | 1982-04-07 | 1983-10-19 | Baylor College of Medicine | Products for use in treating cancer |
| US4663049A (en) * | 1984-07-05 | 1987-05-05 | University Of Utah | Process for therapeutic dissociation of immune complexes and removal of antigens |
| EP0168801A2 (en) * | 1984-07-20 | 1986-01-22 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Apparatus for separating proteins from blood plasma |
| EP0404202A2 (en) * | 1984-07-20 | 1990-12-27 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Agent for separating proteins from blood plasma |
| WO1988001507A1 (en) * | 1986-08-01 | 1988-03-10 | Rubinstein Alan I | A method to treat blood |
| WO2001080866A1 (en) * | 2000-04-26 | 2001-11-01 | Gauchet Jean Yves | Immunostimulatory pharmaceutical composition and its use protocol |
Also Published As
| Publication number | Publication date |
|---|---|
| GB0501156D0 (en) | 2005-03-02 |
| GB2422311A8 (en) | 2006-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02007137A (en) | Liver tissue source. | |
| US20130236428A1 (en) | Reprogramming of Aged Adult Stem Cells | |
| WO2004011631A3 (en) | Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus | |
| CN107517899A (en) | The sea water pearls breeding method of seedless pattra pearl | |
| CN105265353B (en) | There are pearl nucleus of the hydrogel layer containing external carbon dosage and preparation method thereof on a kind of surface | |
| GB2422311A (en) | Treatment of blood to cure disease | |
| EA013526B1 (en) | Method for preparing delicacy foods from ovulated but not fertilized eggs of aquatic animals and delicacy foods prepared therefrom | |
| JP4040413B2 (en) | Nucleation method of pearl shell | |
| Berman et al. | The influence of the flow of detergent and donor characteristics on the extracellular matrix composition after human pancreas decellularization | |
| CN110079575A (en) | A method of extracting low molecular weight collagen from deer sinew | |
| US11499148B2 (en) | Fatty material from which immunity is removed and method for manufacturing same | |
| CN105755001A (en) | Preparation for inhibiting spreading of plant viruses and application of preparation | |
| Mitchell | Outlines of biology | |
| WO2006110843A3 (en) | Engineered deremal tissue particles and transplantation methods | |
| WO2007106203A3 (en) | Systems and methods for sanitizing egg processing equipment | |
| CN106342443A (en) | Method for enhancing white gourd seed germination rate | |
| CN113122604A (en) | Sea intestine glue and preparation method and application thereof | |
| Li et al. | Stem cells, stem cell niche and antler development | |
| CN110117618A (en) | A kind of labeling method of Sepiella maindroni archaeocyte | |
| EP4512437A1 (en) | Multi-stage decellularized tissue supplement, and preparation method thereof | |
| Asashima et al. | Self-organization from organs to embryoids by activin in early amphibian development | |
| CN1159446C (en) | A kind of fish electric pulse sperm transgenic method | |
| CN114286694A (en) | Animal adipose tissue-derived extracellular matrix and animal adipose tissue-derived extracellular matrix preservation solution | |
| CN102188745B (en) | Preparation method of medical suture thread by drawing nutria tail tendon | |
| KR101324508B1 (en) | The method of removing heterologous immunogens and retrovirus in bioscaffold |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) | ||
| APTC | Appeals to the court | ||
| APTC | Appeals to the court |
Free format text: APPEAL DISMISSED; APPEAL WAS DISMISSED. |